BOK and colorectal carcinoma: Because no BOK antibodies are available to detect BOK protein by immunohistochemistry, we employed quantitative western blotting to determine whether BOK protein levels varied in tumour and matched normal tissue (n = 28 matched sample) of resected and quality-assured tumour cases of Stages II and III CRC patients (Table 1).